6 November 2012 – Leading global Trial Master File (TMF) technology and service provider, Phlexglobal, has appointed a new Chief Technology Officer to continue development of the company’s technology innovations and reaffirm its position as The TMF Experts.
Peter McNaney will be responsible for managing large scale technology and service transformation engagements as well as delivering strategic consulting and ongoing technology service delivery to customers. He will advance Phlexglobal’s continuous product development roadmap and manage the configuration and validation of client projects. In addition, Peter will manage the internal IT infrastructure across all UK and US facilities.
Peter commented: “Phlexglobal is synonymous with leading-edge technology solutions and associated services for TMFs and eTMFs (electronic Trial Master Files) and I’m very excited about being a key driver in further developing the portfolio and providing even greater benefits to our clients.”
Phlexglobal is the pioneer of the first commercial eTMF solution – PhlexEview, a customizable, quality-controlled, end-to-end solution enabling electronic searching and viewing of centralized TMF documentation from sponsors, subsidiaries, CROs and field-based personnel from anywhere in the world, at any time.
Peter joins Phlexglobal from Clinical Solutions where he was Executive Vice President, prior to that he was the combined CIO and CTO at IRIS Group, the UK’s largest privately held software company.
Peter added: “I’m currently looking at how we can further enhance our workflows, software capabilities and increase efficiencies in order to significantly expand our already powerful and unique service offering.”
Phlexglobal is a worldwide market leader and specialist in the provision of local and global technology-enabled TMF document management solutions and support services. It offers a unique combination of expert clinical trial knowledge, document management skills, regulatory understanding, technical expertise and training to deliver clinical research support solutions to the pharmaceutical, biotechnology, medical device, CRO and healthcare industries. It counts 17 of the top 20 global pharmaceutical companies amongst its clients.
For more information on Phlexglobal’s range of services visit the website at www.phlexglobal.com
For further information, please contact:
Chrissie Walker
bcsAgency
Tel: 0115 9486900
Email: phlexglobal@bcsagency.com